Gori, G.; De Negri, F.; Fioravanti, A.; De Feo, F.; Castiglioni, C.; Fini, E.
A Single-Group, Open-Label Study on the Systemic Bioavailability, Safety, and Local Tolerability of a New L-Thyroxine/Escin Gel Formulation in Healthy Women. Future Pharmacol. 2025, 5, 33.
https://doi.org/10.3390/futurepharmacol5030033
AMA Style
Gori G, De Negri F, Fioravanti A, De Feo F, Castiglioni C, Fini E.
A Single-Group, Open-Label Study on the Systemic Bioavailability, Safety, and Local Tolerability of a New L-Thyroxine/Escin Gel Formulation in Healthy Women. Future Pharmacology. 2025; 5(3):33.
https://doi.org/10.3390/futurepharmacol5030033
Chicago/Turabian Style
Gori, Giovanni, Ferdinando De Negri, Anna Fioravanti, Francesca De Feo, Catia Castiglioni, and Elisabetta Fini.
2025. "A Single-Group, Open-Label Study on the Systemic Bioavailability, Safety, and Local Tolerability of a New L-Thyroxine/Escin Gel Formulation in Healthy Women" Future Pharmacology 5, no. 3: 33.
https://doi.org/10.3390/futurepharmacol5030033
APA Style
Gori, G., De Negri, F., Fioravanti, A., De Feo, F., Castiglioni, C., & Fini, E.
(2025). A Single-Group, Open-Label Study on the Systemic Bioavailability, Safety, and Local Tolerability of a New L-Thyroxine/Escin Gel Formulation in Healthy Women. Future Pharmacology, 5(3), 33.
https://doi.org/10.3390/futurepharmacol5030033